Trial Details
COMPLETEDBasic Information
| Clinical ID | c4732 |
|---|---|
| Identifier | NCT00055523 |
| Trial Title | A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Adalimumab (D2E7) |
Participant Information
| Sponsor | Abbott |
|---|---|
| City | Berkeley |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2002-04 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |